blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2292748

EP2292748 - Method for producing gamma-carboxylated proteins [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.10.2015
Database last updated on 05.10.2024
Most recent event   Tooltip10.08.2018Lapse of the patent in a contracting state
New state(s): PT		published on 12.09.2018  [2018/37]
Applicant(s)For all designated states
Medlmmune Limited
Milstein Building
Granta Park
Cambridge
CB21 6GH / GB
[2014/51]
Former [2011/46]For all designated states
Medlmmune Limited
Milstein Building
Granta Park
Cambridge
CB21 6GH / GB
Former [2011/10]For all designated states
AstraZeneca AB
151 85 Södertälje / SE
Inventor(s)01 / Fenge, Christel
AstraZeneca R & D Sodertalje
S-151 85, Sodertalje / SE
02 / Lovgren, Ann
AstraZeneca R & D Molndal
S-431 83, Molndal / SE
03 / Thelin, Anders
AstraZeneca R & D Molndal
S-431 83, Molndal / SE
 [2014/51]
Former [2011/10]01 / Fenge, Christel
AstraZeneca R & D Sodertalje
S-151 85, Sodertalje / SE
02 / Lovgren, Ann
AstraZeneca R & D Molndal
S-431 83, Molndal / SE
03 / Thelin, Anders
AstraZeneca R & D Molndal
S-431 83, Molndal / SE
Representative(s)Ttofi, Evangelia
MedImmune Limited
Milstein Building
Granta Park
Cambridge
Cambridgeshire CB21 6GH / GB
[2014/19]
Former [2011/46]Myers, Jonathan David
MedImmune Ltd. Milstein Building Granta Park
Cambridge CB21 6GH / GB
Former [2011/10]Bates, Rosica Florence
Medlmmune Ltd. Milstein Building Granta Park
Cambridge CB21 6GH / GB
Application number, filing date10185166.512.10.2004
[2011/10]
Priority number, dateGB2003002404414.10.2003         Original published format: GB 0324044
[2011/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2292748
Date:09.03.2011
Language:EN
[2011/10]
Type: B1 Patent specification 
No.:EP2292748
Date:17.12.2014
Language:EN
[2014/51]
Search report(s)(Supplementary) European search report - dispatched on:EP27.01.2011
ClassificationIPC:C12N9/64, C12N9/74, C12P21/02
[2011/10]
CPC:
C12N9/647 (EP,NO,US); C12N9/6429 (EP,NO,US); C12N15/63 (KR);
A61P7/02 (EP); A61P7/04 (EP); C12P21/02 (EP,NO,US);
C12Y304/21005 (EP,NO,US); A61K38/00 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/10]
Extension statesAL01.10.2010
HR01.10.2010
LT01.10.2010
LV01.10.2010
MK01.10.2010
TitleGerman:Verfahren zur Herstellung gamma-carboxylierter Proteine[2011/10]
English:Method for producing gamma-carboxylated proteins[2011/10]
French:Procédé de fabrication des protéines gamma-carboxylées[2011/10]
Examination procedure08.09.2011Amendment by applicant (claims and/or description)
08.09.2011Examination requested  [2011/42]
18.10.2011Despatch of a communication from the examining division (Time limit: M06)
27.04.2012Reply to a communication from the examining division
10.05.2012Despatch of a communication from the examining division (Time limit: M04)
06.09.2012Reply to a communication from the examining division
18.09.2012Despatch of a communication from the examining division (Time limit: M04)
25.01.2013Reply to a communication from the examining division
02.07.2014Communication of intention to grant the patent
05.11.2014Fee for grant paid
05.11.2014Fee for publishing/printing paid
05.11.2014Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP04775534.3  / EP1678297
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20040775534) is  19.12.2006
Opposition(s)18.09.2015No opposition filed within time limit [2015/48]
Fees paidRenewal fee
01.10.2010Renewal fee patent year 03
01.10.2010Renewal fee patent year 04
01.10.2010Renewal fee patent year 05
01.10.2010Renewal fee patent year 06
25.10.2010Renewal fee patent year 07
25.10.2011Renewal fee patent year 08
25.10.2012Renewal fee patent year 09
28.10.2013Renewal fee patent year 10
27.10.2014Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU12.10.2004
AT17.12.2014
BE17.12.2014
BG17.12.2014
CY17.12.2014
CZ17.12.2014
DK17.12.2014
EE17.12.2014
FI17.12.2014
MC17.12.2014
PL17.12.2014
PT17.12.2014
RO17.12.2014
SI17.12.2014
SK17.12.2014
TR17.12.2014
GR18.03.2015
[2018/37]
Former [2017/39]HU12.10.2004
AT17.12.2014
BE17.12.2014
BG17.12.2014
CY17.12.2014
CZ17.12.2014
DK17.12.2014
EE17.12.2014
FI17.12.2014
MC17.12.2014
PL17.12.2014
RO17.12.2014
SI17.12.2014
SK17.12.2014
TR17.12.2014
GR18.03.2015
Former [2016/28]AT17.12.2014
BE17.12.2014
CZ17.12.2014
DK17.12.2014
EE17.12.2014
FI17.12.2014
MC17.12.2014
PL17.12.2014
RO17.12.2014
SI17.12.2014
SK17.12.2014
GR18.03.2015
Former [2016/24]AT17.12.2014
BE17.12.2014
CZ17.12.2014
DK17.12.2014
EE17.12.2014
FI17.12.2014
PL17.12.2014
RO17.12.2014
SI17.12.2014
SK17.12.2014
GR18.03.2015
Former [2016/12]AT17.12.2014
CZ17.12.2014
DK17.12.2014
EE17.12.2014
FI17.12.2014
PL17.12.2014
RO17.12.2014
SI17.12.2014
SK17.12.2014
GR18.03.2015
Former [2015/50]AT17.12.2014
CZ17.12.2014
DK17.12.2014
EE17.12.2014
FI17.12.2014
PL17.12.2014
RO17.12.2014
SK17.12.2014
GR18.03.2015
Former [2015/38]AT17.12.2014
CZ17.12.2014
EE17.12.2014
FI17.12.2014
PL17.12.2014
RO17.12.2014
SK17.12.2014
GR18.03.2015
Former [2015/37]CZ17.12.2014
EE17.12.2014
FI17.12.2014
PL17.12.2014
RO17.12.2014
SK17.12.2014
GR18.03.2015
Former [2015/36]CZ17.12.2014
EE17.12.2014
FI17.12.2014
RO17.12.2014
GR18.03.2015
Former [2015/35]EE17.12.2014
FI17.12.2014
GR18.03.2015
Former [2015/24]FI17.12.2014
GR18.03.2015
Former [2015/23]FI17.12.2014
Documents cited:Search[XY]WO0229045  (NOVO NORDISK AS [DK], et al) [X] 1-14 * pages 11, 19 * * claim 7 * [Y] 1-14;
 [X]  - HALLGREN K W ET AL, "Carboxylase overexpression effects full carboxylation but poor release and secretion of factor IX: Implications for the release of vitamin K-dependent proteins", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (20020101), vol. 41, doi:10.1021/BI026016E, ISSN 0006-2960, pages 15045 - 15055, XP002983284 [X] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1021/bi026016e
 [Y]  - LUCAS BRIAN K ET AL, "High-level production of recombinant proteins in CHO cells using a dicistronic DHFR intron expression vector", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, (19960101), vol. 24, no. 9, doi:10.1093/NAR/24.9.1774, ISSN 0305-1048, pages 1774 - 1779, XP002151702 [Y] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1093/nar/24.9.1774
by applicantWO8803926
 WO9219636
    - RODDIE; LUDLAM, BLOOD REV., (1997), vol. 11, pages 169 - 177
    - WU ET AL., SCIENCE, (1991), vol. 254, no. 5038, pages 1634 - 1636
    - REHEMTULLA ET AL., PROC NATL ACAD SCI USA, (1993), vol. 90, pages 4611 - 4615
    - STANLEY, J. BIOL. CHEM., (1999), vol. 274, no. 24, pages 16940 - 16944
    - VO ET AL., FEBS LETTERS, (1999), vol. 445, pages 256 - 260
    - BEGLEY ET AL., THE JOURNAL OF BIOLOGICAL CHEMISTRY, (2000), vol. 275, no. 46, pages 36245 - 36249
    - WALKER ET AL., THE JOURNAL OF BIOLOGICAL CHEMISTRY, (2001), vol. 276, no. 11, pages 7769 - 7774
    - BANDYOPADHYAY ET AL., PROC NATL ACAD SCI USA, (2002), vol. 99, no. 3, pages 1264 - 1269
    - CZERWIEC ET AL., EUR J BIOCHEM, (2002), vol. 269, pages 6162 - 6172
    - HALLGREN ET AL., BIOCHEMISTRY, (2002), vol. 41, no. 50, pages 15045 - 15055
    - HARVEY ET AL., THE JOURNAL OF BIOLOGICAL CHEMISTRY, (2003), vol. 278, no. 10, pages 8363 - 8369
    - MALHOTRA ET AL., J. BIOL. CHEM., (1985), vol. 260, pages 279 - 287
    - JøRGENSEN ET AL., J. BIOL. CHEM., (1987), vol. 262, pages 6729 - 6734
    - RUSSO ET AL., BIOTECHNOL APPL BIOCHEM, (1991), vol. 14, no. 2, pages 222 - 233
    - FISCHER ET AL., J BIOTECHNOL, (1995), vol. 38, no. 2, pages 129 - 136
    - HERLITSCHKA ET AL., PROTEIN EXPR. PURIF., (1996), vol. 8, no. 3, pages 358 - 364
    - RUSSO ET AL., PROTEIN EXPR. PURIF., (1997), vol. 10, pages 214 - 225
    - WU; SUTTIE, THROMB RES, (1999), vol. 96, no. 2, pages 91 - 98
    - COTE ET AL., J. BIOL. CHEM, (1994), vol. 269, pages 11374 - 11380
    - BOSHART ET AL., CELL, (1985), vol. 41, pages 521 - 530
    - WENGER ET AL., ANAL BIOCHEM, (1994), vol. 221, pages 416 - 418
    - MIZUSHIMA; NAGATA, NUC ACIDS RES, (1990), vol. 18, page 5322
    - GOLDMAN ET AL., BIOTECHNIQUES, (1996), vol. 21, pages 1013 - 1015
    - GORMAN ET AL., PROC NATL ACAD SCI USA, (1982), vol. 79, pages 6777 - 6781
    - SCHORPP ET AL., NUC ACIDS RES, (1996), vol. 24, pages 1787 - 1788
    - ROUET ET AL., THE JOURNAL OF BIOLOGICAL CHEMISTRY, (1992), vol. 267, pages 20765 - 20773
    - KOZAK, NUC ACIDS RES, (1987), vol. 15, pages 8125 - 8148
    - KOZAK, PROC NATL ACAD SCI USA, (1990), vol. 87, pages 8301 - 83051987
    - BERKNER; PUDOTA, PROC NATL ACAD SCI USA., (1998), vol. 95, pages 446 - 471
    - LINGENFELTER ET AL., BIOCHEMISTRY, (1996), vol. 35, pages 8234 - 8243
    - BERKNER ET AL., PROC NATL ACAD SCI USA, (1998), vol. 95, pages 446 - 471
    - BERKNER ET AL., PROC NATL ACAD SCI USA, (1992), vol. 89, pages 6242 - 6246
    - Comprehensive Medicinal Chemistry, PERGAMON PRESS, (1990), vol. 5
    - Drugs and the pharmaceutical sciences; Protein formulation and delivery, MARCEL DEKKER INC, (2000), vol. 99
    - DNA Cloning 3: A Practical Approach, IRL PRESS, (1995), vol. I, II, I
    - Methods in Enzymology, ACADEMIC PRESS
    - JOSIC ET AL., JOURNAL OF CHROMATOGRAPHY B, (2003), vol. 790, pages 183 - 197
    - MAO ET AL., JBC, (1998), vol. 273, pages 30086 - 30091
    - STIG ET AL., BLOOD COAGULATION AND FIBRINOLYSIS, (2003), vol. 14, pages 457 - 462
    - BERKNER; PUDOTA, PROC NATL ACAD SCI USA, (1998), vol. 95, pages 446 - 471
    - LINGENFELTER; BERKNER, BIOCHEMISTRY, (1996), vol. 35, pages 8234 - 8243
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.